WuXi AppTec Selects H-Cube(R) from ThalesNano for Laboratory-based Hydrogenation
company of WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology
and medical device research and development outsourcing company with
operations in
H-Cube(R) from ThalesNano Inc. for laboratory-based hydrogenation. WuXi thus
joins all the top 20 pharmaceutical companies worldwide that have introduced
and adopted the H-Cube technology.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
“WuXi AppTec is one of the largest CRO companies in the world, providing
the best services to pharmaceutical, biotechnology and medical device research
and development industries. We are very glad to supply WuXi with our technique,
best service and application,” commented Dr. Urge, CEO of ThalesNano Zrt.
“We are very pleased for the employment of H-Cube, as Hydrogenation in
flow for drug discovery is significantly a more productive and safer approach
than traditional batch-based technique. We are looking forward to working with
ThalesNano as we move to larger scale in the future,” commented
Chief Scientific Officer of WuXi AppTec.
The H-Cube(R) Continuous-flow Hydrogenation Reactor is a bench-top
standalone hydrogenation device, uniquely combining continuous-flow
microchemistry with endogenous on-demand hydrogen generation and a disposable
catalyst cartridge system. Compared to conventional methods, it allows safer,
faster and more cost-efficient hydrogenation with superior yield. The H-Cube
and the other novel Cube series flow reactor systems developed by ThalesNano
Inc. are showing tremendous benefits in the drug discovery process including
shortened development time, increased cost efficiency and reduced
environmental impact.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical
device R&D outsourcing company, with operations in
As a research-driven and customer-focused company, WuXi PharmaTech provides
pharmaceutical, biotechnology and medical device companies a broad and
integrated portfolio of laboratory and manufacturing services throughout the
drug and medical device R&D process. WuXi PharmaTech’s services are designed
to assist its global partners in shortening the cycle and lowering the cost of
drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are
known as WuXi AppTec. For more information, please visit:
http://www.wuxiapptec.com .
For more information, please contact:
Sherry Shao
WuXi PharmaTech (Cayman) Inc.
Tel: +86-21-5046-4002
Email: pr@wuxiapptec.com
SOURCE WuXi PharmaTech (Cayman) Inc.
